Navigation Links
Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues
Date:5/12/2008

NEW YORK, May 12 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) commends the Senate on its passage of a resolution supporting the goals and ideals of National Women's Health Week that begins annually on Mother's Day. The resolution, introduced by Senators Russ Feingold (D-WI) and Olympia Snowe (R-ME) calls on all Americans to take the week of May 11th - May 17th as an opportunity to educate themselves on women's health issues, and recognizes the importance of Federally funded programs that provide research on common diseases in women, like lupus. ALR's main legislative priority is increased support for lupus research by Federal agencies such as the National Institute for Health, Health and Human Services, and Department of Defense Health Programs. The House version of the resolution introduced by Rep. Maurice Hinchey (NY-D) is expected to pass this week.

"Too many women - our nation's mothers, daughters, sisters, and grandmothers - are affected by lupus, a devastating autoimmune disease. We are pleased that Congress is honoring National Women's Health Week along with the ALR, by officially recognizing the importance of education and continued Federal research funding for lupus and other women's health issues," says ALR President Barbara Boyts.

Lupus causes unpredictable symptoms ranging from fatigue and joint pain to severe organ damage, and complications from the disease often prove fatal. The resolution properly recognizes that significant disparities exist in the prevalence of disease among women of different backgrounds. Not only are women in their childbearing years nine times more likely than men to develop lupus, but women of African-American descent are three times more likely to be diagnosed with the disease. Women of Asian, Latin American/Hispanic, Pacific Rim descent are also more likely to be affected. An estimated 1.4 million Americans have lupus.

"This disease disproportionately strikes a typically me
'/>"/>

SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
2. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
3. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
6. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
7. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Aida Announces New Anti-Cancer Drug Under Development
10. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
11. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...tage A of Trial Assessing Regimen of Bavituxima..., TUSTIN, Calif., Oct. 7 /..., a clinical stage biopharmaceutical,company devel...ancer and,hepatitis C virus (HCV) infection, today... first stage of a Phase II trial of bavituximab in...
(Date:10/6/2008)...ollege of Gastroenterology Annual ...Newswire/ -- Combined results from two Phase 3,stu...terology Annual,Scientific Meeting (ACG) in Orland...igher healing rates than lansoprazole among patien...(EE). TAK-390MR combines,dexlansoprazole with a Du...
(Date:10/6/2008)...te to Improve Patient Safety, WASHINGTON, Oct. 6 ...,Cardiology in collaboration with the American Col...sociation today released consensus guidelines,outl... ulcers and,gastrointestinal (GI) bleeding among p... (NSAIDs) along with antiplatelet agents., Gastro...
(Date:10/6/2008).... 6 /- Complete,Genomics Inc., a newl...ng,company, and the Institute for Systems Biology ... populationwide human genome studies., In phase o...proprietary,DNA sequencing technology to sequence ...nce proof-of-concept has been demonstrated, ISB an...
Breaking Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 2Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 1125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 2125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 3125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 4Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 1Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 2Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 3Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 1New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 7LUMEDX Updates Real Time Patient and Resource Scheduler for Healthcare Systems 4095 1LUMEDX Updates Real Time Patient and Resource Scheduler for Healthcare Systems 4095 2
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2007 -...ompany focused on,the discovery and development of... findings from its novel human-in-mouse (HIM) tiss...uccessfully created,invasive human tumors that dev...issue. This model enables scientists, for the firs...
...INESS WIRE)--Apr 19, 2007 - Antares Pharma, Inc.,(...tly completed,site application study demonstrating...mal gel, was absorbed on a bioequivalent,basis aft...in site,locations., The study was an open-label, c...harmacokinetic study. The trial enrolled 25,health...
Other Medicine Technology:Novel Human Tissue Transgenic Cancer Model May Offer Significant,Advance Toward Accurately Modeling Human Cancer 2Novel Human Tissue Transgenic Cancer Model May Offer Significant,Advance Toward Accurately Modeling Human Cancer 3Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
... the Vanderbilt University say that constant expos...mal development of premature babies' biological// ... Research. The researchers found that the lighting...aster biological clock in the babies. Earlier res...
...ain-crushing headache, you are probably better off...owing the regulatory doses of aspirin, according//...The study found that salicylic acid, the active in...rtain Indian spices like cumin, turmeric and papri...
...ive at Martin Luther King Jr./Drew Medical Center ...n, it will endeavor to get back the accreditation ...rauma care. Antionette Smith Epps, chief executi...of the new leadership team that is determined to i...
...annual back-to-school survey on teens' attitudes t...arents clueless about children’s immoral practices...ded parties where alcohol or illegal drugs were us...It doesn’t imply that parents were aware of what w...
Other Medicine News:Health News:Parents ignorant about kids' immoral practices 2
Cholesterol/HDL Standard 50 mg/dl.
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Ammonia reagent is used for the quantitative and enzymatic determination of ammonia in human plasma.
Medicine Products: